Zacks Investment Management’s Ingevity NGVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-48,238
Closed -$1.91M 749
2025
Q1
$1.91M Buy
+48,238
New +$2.13M 0.02% 330
2020
Q1
Sell
-15,657
Closed -$1.37M 564
2019
Q4
$1.37M Sell
15,657
-1,454
-8% -$127K 0.03% 341
2019
Q3
$1.45M Sell
17,111
-527
-3% -$47K 0.03% 324
2019
Q2
$1.85M Sell
17,638
-4,481
-20% -$450K 0.04% 284
2019
Q1
$2.34M Buy
22,119
+15,537
+236% +$1.56M 0.05% 236
2018
Q4
$551K Sell
6,582
-23,342
-78% -$2.11M 0.01% 429
2018
Q3
$3.05M Buy
29,924
+1,296
+5% +$125K 0.06% 204
2018
Q2
$2.31M Sell
28,628
-700
-2% -$55.6K 0.05% 245
2018
Q1
$2.16M Buy
29,328
+6,856
+31% +$513K 0.05% 249
2017
Q4
$1.58M Buy
+22,472
New +$1.62M 0.03% 312

Other funds holding NGVT

Zacks Investment Management's NGVT Position: Q2 2025 in Review

Zacks Investment Management sold out of Ingevity (NGVT) in Q2 2025, closing a stake of 48,238 shares — an estimated $1.91M sold.

Zacks Investment Management first reported a position in NGVT in Q4 2017 and held it in 10 quarters. The position peaked at $3.05M in Q3 2018. 269 funds tracked by Wall St. Rank hold NGVT as of Q2 2025.

  • Zacks Investment Management reported no remaining Ingevity position as of Q2 2025 after selling out during the quarter.
  • Zacks Investment Management sold 48,238 Ingevity shares in Q2 2025, an estimated $1.91M.
  • Zacks Investment Management first reported a position in Ingevity in Q4 2017 and held it in 10 quarters.
  • Zacks Investment Management's Ingevity position peaked at $3.05M in Q3 2018.
  • 269 funds tracked by Wall St. Rank held Ingevity as of Q2 2025.

Based on Zacks Investment Management's 13F filing for Q2 2025, filed 12 Aug 2025.